
On May 24, 2026, Indonesia’s National Agency of Drug and Food Control (BPOM) implemented new labeling requirements for cosmetic packaging—covering both finished products and empty packaging components such as bottles, tubes, pumps, and makeup boxes. The rule mandates full INCI name disclosure in Bahasa Indonesia on the smallest retail unit, along with locally adapted safety warnings (e.g., ‘For external use only’, ‘Avoid contact with eyes’). Non-compliant shipments face customs rejection, directly impacting time-to-market for skincare OEMs and brand owners.
Effective May 24, 2026, BPOM requires all imported cosmetic products and cosmetic packaging—including empty containers (e.g., bottles, tubes, pump dispensers, rigid color cosmetic boxes)—to display complete INCI ingredient names in Bahasa Indonesia on the smallest sales unit. Additionally, mandatory local-language precautionary statements must be included, such as ‘For external use only’ and ‘Avoid contact with eyes’. Shipments failing to meet these labeling criteria will be denied customs clearance.
Direct Importers & Exporters
These entities handle cross-border shipment documentation and customs declarations. Non-compliant labeling triggers immediate release delays or rejection at Indonesian ports, increasing demurrage costs and disrupting launch timelines. Impact manifests primarily in clearance failure, inventory hold-ups, and rework logistics.
OEM/ODM Manufacturers (Skincare & Cosmetics)
Manufacturers supplying private-label or contract-packaged goods must now adapt artwork, printing plates, and packaging specifications per BPOM’s language and content rules—even for empty vessels supplied to brands. This affects design lead time, print vendor coordination, and sample approval cycles.
Packaging Component Suppliers
Suppliers of tubes, airless pumps, folding cartons, and other cosmetic-grade packaging must ensure that any unit sold into Indonesia—whether filled or empty—carries compliant labeling. This introduces new compliance obligations upstream, particularly for standardized SKUs distributed across multiple markets.
Distribution & Brand Operations Teams
Brands managing regional inventory or third-party fulfillment in Indonesia must verify label conformity before warehousing or e-commerce listing. Non-compliant stock may be blocked from sale on local platforms (e.g., Tokopedia, Shopee), affecting campaign execution and shelf availability.
While the regulation took effect on May 24, 2026, BPOM may issue clarifications on scope (e.g., whether ‘empty packaging’ includes bulk-quantity shipments not intended for end consumers) or transitional arrangements. Stakeholders should track updates via BPOM’s official portal and registered trade associations.
Focus first on products with imminent import schedules or active listings on Indonesian e-commerce platforms. Prioritize SKUs where packaging is co-branded, multi-market, or uses shared artwork templates—these carry highest risk of non-compliance due to language or warning omissions.
The rule reflects BPOM’s broader emphasis on consumer transparency and post-market traceability—not just cosmetic ingredients but also packaging material safety. However, its immediate operational impact remains confined to labeling format and language; it does not introduce new testing, registration, or pre-market approval requirements for packaging alone.
Integrate Bahasa Indonesia INCI translation and approved warning statements into packaging development checklists. Require suppliers to submit label mockups for BPOM compliance review prior to plate engraving or production—especially for SKUs with tight Q3/Q4 2026 launch windows.
Observably, this requirement signals a tightening of regulatory oversight at the point of entry—not just for formulations, but for the physical delivery system of cosmetics. Analysis shows BPOM is extending its consumer protection mandate downstream into packaging, aligning more closely with EU and ASEAN harmonization trends. It is currently best understood as an enforcement-driven compliance checkpoint rather than a broad policy shift; however, its precedent may inform future labeling or sustainability-related mandates in Indonesia. Continued attention is warranted—not because it reshapes market access broadly, but because it introduces a new, non-negotiable gate in the import workflow.

This update underscores how localized regulatory execution—rather than headline-grabbing legislation—increasingly defines operational viability in Southeast Asian markets. For stakeholders, the takeaway is not about systemic disruption, but about precision: accurate INCI translation, validated local phrasing, and timely alignment across global supply chain touchpoints.
Source: Indonesia National Agency of Drug and Food Control (BPOM) official announcement, effective May 24, 2026.
Note: Clarifications regarding scope (e.g., applicability to B2B bulk packaging) remain under observation and are not yet confirmed by BPOM.
Related Intelligence